Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial.
Dinneen E, Haider A, Grierson J, Freeman A, Oxley J, Briggs T, Nathan S, Williams NR, Brew-Graves C, Persad R, Aning J, Jameson C, Ratynska M, Ben-Salha I, Ball R, Clow R, Allen C, Heffernan-Ho D, Kelly J, Shaw G. Dinneen E, et al. Among authors: ball r. BJU Int. 2021 Jun;127(6):676-686. doi: 10.1111/bju.15256. Epub 2021 Mar 29. BJU Int. 2021. PMID: 32985121 Clinical Trial.
Prostate cancer visibility on multiparametric magnetic resonance imaging: high Gleason grade and increased tumour volume are not the only important histopathological features.
Norris JM, Carmona Echeverria LM, Simpson BS, Allen C, Ball R, Freeman A, Kelly D, Kirkham A, Kasivisvanathan V, Whitaker HC, Emberton M. Norris JM, et al. Among authors: ball r. BJU Int. 2020 Aug;126(2):237-239. doi: 10.1111/bju.15085. Epub 2020 May 18. BJU Int. 2020. PMID: 32319152 No abstract available.
Mixed acinar and macrocystic ductal prostatic adenocarcinoma.
Giganti F, Allen C, Sridhar A, Tandogdu Z, Ramachandran N, Dickinson L, Haider A, Freeman A, Ball R, Moore CM. Giganti F, et al. Among authors: ball r. Lancet Oncol. 2021 Jan;22(1):e37. doi: 10.1016/S1470-2045(20)30435-6. Lancet Oncol. 2021. PMID: 33387504 No abstract available.
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis J Urol 2020; doi: 10.1097/JU.0000000000001157.
Stavrinides V, Giganti F, Punwani S, Allen C, Kirkham A, Freeman A, Ball R, Haider A, Whitaker H, Orczyk C, Emberton M, Moore CM. Stavrinides V, et al. Among authors: ball r. J Urol. 2020 Nov;204(5):1065-1066. doi: 10.1097/JU.0000000000001295. Epub 2020 Jul 23. J Urol. 2020. PMID: 32698715 No abstract available.
Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy.
Morka N, Simpson BS, Ball R, Freeman A, Kirkham A, Kelly D, Whitaker HC, Emberton M, Norris JM. Morka N, et al. Among authors: ball r. BMJ Open. 2021 May 5;11(5):e047664. doi: 10.1136/bmjopen-2020-047664. BMJ Open. 2021. PMID: 33952556 Free PMC article.
1,217 results